Capital Flow Monitor · Sponsors · CIK 1671584
Aptevo Therapeutics Inc.
2401 4th Ave., Seattle, WA, 98121 · 206-838-0500
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$3.5M
Sold
$3.5M
% sold
100.0%
Investors
3
Min investment
$0
Exemption
506(c)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-26 | D ·current | 506(c) | $3.5M | $3.5M | 100.0% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Jeffrey G Lamothe — Executive Officer / Director, Seattle, WA
- Marvin L White — Executive Officer / Director, Seattle, WA
- Daphne Taylor — Executive Officer, Seattle, WA
- John E Niederhuber — Director, Seattle, WA
- Daniel J Abdun-Nabi — Director, Seattle, WA
- Grady Grant III — Director, Seattle, WA
- Zsolt Harsanyi — Director, Seattle, WA
- Barbara Lopez Kunz — Director, Seattle, WA
Placement agents
- Roth Capital Partners, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.